Adhezion Biomedical

Wyomissing, United States Founded: 2001 • Age: 25 yrs Acquired By HB Fuller
Developer of cyanoacrylate based surgical, wound management, and infection prevention products
Request Access

About Adhezion Biomedical

Adhezion Biomedical is a company based in Wyomissing (United States) founded in 2001 was acquired by HB Fuller in June 2023.. Adhezion Biomedical has raised $10.14 million across 5 funding rounds from investors including HB Fuller. Adhezion Biomedical offers products and services including SurgiSeal®, FloraSeal®, SecurePortIV®, and Histoacryl®. Adhezion Biomedical operates in a competitive market with competitors including HyperBranch Medical, BRIJ Medical, BORAYER, Inno Therapy and Mussel Polymers, among others.

  • Headquarter Wyomissing, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Adhezion Biomedical, Llc
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $10.14 M (USD)

    in 5 rounds

  • Latest Funding Round
    $3 M (USD), Series A

    Dec 29, 2020

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    HB Fuller

    (Jun 22, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Adhezion Biomedical

Adhezion Biomedical offers a comprehensive portfolio of products and services, including SurgiSeal®, FloraSeal®, SecurePortIV®, and Histoacryl®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides strength and flexibility for effective wound closure.

Prevents bacteria migration during and after surgical procedures.

Offers securement for vascular access devices to protect sites.

Acts as a microbial barrier with strong tensile strength for wounds.

People of Adhezion Biomedical
Headcount 10-50
Employee Profiles 11
Employee Profiles
People
Pete Molinaro
Chairman & CEO
People
John Prelaz
VP, Business Development
People
Janet Huntsinger
Director, Quality Assurance & Regulatory Affairs
People
Richard G. Jones
Clinical Regulatory & Quality Assurance Consultant

Unlock access to complete

Funding Insights of Adhezion Biomedical

Adhezion Biomedical has successfully raised a total of $10.14M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series A — $3.0M
  • First Round

    (25 Feb 2010)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2020 Amount Series A - Adhezion Biomedical Valuation

investors

Aug, 2018 Amount Series A - Adhezion Biomedical Valuation

investors

Jul, 2011 Amount Series A - Adhezion Biomedical Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Adhezion Biomedical

Adhezion Biomedical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HB Fuller. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Adhesives and sealants are manufactured for diverse industries.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Adhezion Biomedical

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Adhezion Biomedical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Adhezion Biomedical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Adhezion Biomedical

Adhezion Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HyperBranch Medical, BRIJ Medical, BORAYER, Inno Therapy and Mussel Polymers, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biosurgical devices are developed using proprietary polymers and hydrogels.
domain founded_year HQ Location
Medical devices for post-surgical and trauma incision care are provided.
domain founded_year HQ Location
Biomaterials for surgery and wound repair are developed.
domain founded_year HQ Location
Hemostatic polymers are produced for surgical and wound care applications.
domain founded_year HQ Location
Adhesive solutions are manufactured for diverse materials and applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Adhezion Biomedical

Frequently Asked Questions about Adhezion Biomedical

When was Adhezion Biomedical founded?

Adhezion Biomedical was founded in 2001 and raised its 1st funding round 9 years after it was founded.

Where is Adhezion Biomedical located?

Adhezion Biomedical is headquartered in Wyomissing, United States. It is registered at Wyomissing, Pennsylvania, United States.

Is Adhezion Biomedical a funded company?

Adhezion Biomedical is a funded company, having raised a total of $10.14M across 5 funding rounds to date. The company's 1st funding round was a Series A of $250K, raised on Feb 25, 2010.

What does Adhezion Biomedical do?

Adhezion Biomedical is a developer of cyanoacrylate based surgical, wound management, and infection prevention products. It focused on the development and commercialization of highly differentiated cyanoacrylate based surgical, wound management and infection prevention technologies for use in professional and consumer healthcare settings. Its products are manufactured using proprietary patented OctylFlex technology. Its professional products include topical skin adhesive (surgical), microbial sealant (for infection prevention), and topical wound care products for consumers.

Who are the top competitors of Adhezion Biomedical?

Adhezion Biomedical's top competitors include BRIJ Medical, Inno Therapy and HyperBranch Medical.

What products or services does Adhezion Biomedical offer?

Adhezion Biomedical offers SurgiSeal®, FloraSeal®, SecurePortIV®, and Histoacryl®.

Who are Adhezion Biomedical's investors?

Adhezion Biomedical has 1 investor. Key investors include HB Fuller.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available